HPLC Separation of Atenolol on Legacy L1 Column

Atenolol is a selective beta receptor antagonist, a drug belonging to beta blockers. The USP method was reproduced on the L1 column. This method can be used for the analysis of atenolol by reversed-phase chromatography on a typical C18 HPLC column. Column and method can be used for other drug substances, intermediates and impurities which need to be analyzed according to the United States Pharmacopeia. Application Notes: Atenolol is a beta blocker used to treat heart disease as well as thyroid disorders and alcohol withdrawal. The USP HPLC method for the separation of atenolol was developed on Legacy L1 column according to the US Pharmacopeia methodology. L1 classification is assigned to reversed-phase HPLC column containing C18 ligand. Support for the material is spherical silica gel with particles size 3-10 um and pore size of 100-120A. Resolution between critical pairs corresponds to rules and specifications of UPS.


Column Primesep 100, 4.6x150 mm, 5 µm, 100A
Mobile Phase MeCN
Buffer Octanesulfonic Acid, Sulfuric Acid
Flow Rate 1.0 ml/min
Detection UV, 270 nm


Class of Compounds Drug, Beta blocker, Hydrophobic, Ionizable
Analyzing Compounds Atenolol
SIELC Technologies usually develops more than one method for each compound on our website. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound of interest.
Application Analytes:

Application Detection:
UV Detection